What is different about serotype 1 pneumococci?
- PMID: 22191445
- DOI: 10.2217/fmb.11.146
What is different about serotype 1 pneumococci?
Abstract
Serotype 1 Streptococcus pneumoniae is among the most commonly isolated serotype in invasive pneumococcal disease but is rarely found causing asymptomatic nasopharyngeal colonization. Compared to infection by other serotypes, infection caused by serotype 1 is more likely to be identified in young patients without comorbidities but is generally associated with a lower mortality. Empyema and extrapulmonary manifestations are common. Outbreaks of serotype 1 disease have been reported in closed communities and epidemics are particularly common in sub-Saharan Africa. The serotype 1 capsular polysaccharide is a zwitterionic structure that enables it to function as a T-cell dependent antigen under some circumstances, in contrast to other pneumococcal capsular polysaccharides that are T-cell independent antigens. There are also differences in the key virulence factor pneumolysin in some serotype 1 isolates. The clinical significance of these differences remains to be determined.
Similar articles
-
The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.Immunobiology. 2010 Apr;215(4):251-63. doi: 10.1016/j.imbio.2009.12.004. Epub 2009 Dec 28. Immunobiology. 2010. PMID: 20071053
-
Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks.J Infect Dis. 2007 Sep 15;196(6):936-44. doi: 10.1086/520091. Epub 2007 Aug 6. J Infect Dis. 2007. PMID: 17703426
-
The capsular serotype of Streptococcus pneumoniae is more important than the genetic background for resistance to complement.Infect Immun. 2010 Dec;78(12):5262-70. doi: 10.1128/IAI.00740-10. Epub 2010 Sep 20. Infect Immun. 2010. PMID: 20855513 Free PMC article.
-
Pneumococcal vaccines: mechanism of action, impact on epidemiology and adaption of the species.Int J Antimicrob Agents. 2008 Sep;32(3):199-206. doi: 10.1016/j.ijantimicag.2008.01.021. Epub 2008 Apr 18. Int J Antimicrob Agents. 2008. PMID: 18378430 Review.
-
Impact of pneumococcal conjugate vaccine on infections caused by antibiotic-resistant Streptococcus pneumoniae.Clin Microbiol Infect. 2009 Apr;15 Suppl 3:16-20. doi: 10.1111/j.1469-0691.2009.02726.x. Clin Microbiol Infect. 2009. PMID: 19366365 Review.
Cited by
-
Emerging pneumococcal serotypes in Iraq: scope for improved vaccine development.F1000Res. 2023 Dec 28;12:435. doi: 10.12688/f1000research.132781.2. eCollection 2023. F1000Res. 2023. PMID: 38283903 Free PMC article. Review.
-
Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among sick and healthy children in northern India: A case-control study.Vaccine. 2023 Oct 20;41(44):6619-6624. doi: 10.1016/j.vaccine.2023.09.029. Epub 2023 Sep 26. Vaccine. 2023. PMID: 37758571 Free PMC article.
-
Serotype 1 pneumococcus: epidemiology, genomics, and disease mechanisms.Trends Microbiol. 2022 Jun;30(6):581-592. doi: 10.1016/j.tim.2021.11.007. Epub 2021 Dec 20. Trends Microbiol. 2022. PMID: 34949516 Free PMC article. Review.
-
Changes in Invasive Pneumococcal Disease Caused by Streptococcus pneumoniae Serotype 1 Following Introduction of PCV10 and PCV13: Findings from the PSERENADE Project.Microorganisms. 2021 Mar 27;9(4):696. doi: 10.3390/microorganisms9040696. Microorganisms. 2021. PMID: 33801760 Free PMC article.
-
Pneumococcal nasopharyngeal carriage among Bhutanese children hospitalized with clinical pneumonia: serotypes and viral co-infection.BMC Infect Dis. 2020 Dec 9;20(1):940. doi: 10.1186/s12879-020-05674-4. BMC Infect Dis. 2020. PMID: 33297987 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
